U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07548632) titled 'A Clinical Study Evaluating Licaminlimab for Dry Eye Disease' on April 16.
Brief Summary: The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Study Start Date: April 16
Study Type: INTERVENTIONAL
Condition:
Dry Eye Disease (DED)
Intervention:
OTHER: Artificial Tear Run-in
Artificial tear eye drop run-in three times daily (TID) for approximately 14 days.
DRUG: licaminlimab
Licaminlimab eye drops three times daily (TID) for 29 days.
OTHER: Vehicle of licaminlima...